Keryx Recalls Auryxia Tablets Due to Manufacturing Process Deviations
Keryx Biopharmaceuticals is recalling 59,820 bottles of Auryxia (ferric citrate) tablets because they were not manufactured in conformance with the FDA-approved process.
- Product
- AURYXIA — AURYXIA (FERRIC CITRATE)
- Category
- Drug
- Distribution
- Distributed nationwide